SCYB | USHY | SCYB / USHY | |
Gain YTD | 4.324 | 4.640 | 93% |
Net Assets | 1.21B | 24.7B | 5% |
Total Expense Ratio | 0.03 | 0.08 | 38% |
Turnover | 24.00 | 21.00 | 114% |
Yield | 6.99 | 6.70 | 104% |
Fund Existence | 2 years | 8 years | - |
SCYB | USHY | |
---|---|---|
RSI ODDS (%) | 2 days ago32% | 2 days ago47% |
Stochastic ODDS (%) | 2 days ago67% | 2 days ago63% |
Momentum ODDS (%) | 2 days ago42% | 2 days ago50% |
MACD ODDS (%) | 2 days ago58% | 2 days ago52% |
TrendWeek ODDS (%) | 2 days ago34% | 2 days ago52% |
TrendMonth ODDS (%) | 2 days ago69% | 2 days ago56% |
Advances ODDS (%) | 15 days ago73% | 15 days ago61% |
Declines ODDS (%) | 7 days ago30% | 7 days ago54% |
BollingerBands ODDS (%) | 2 days ago27% | 2 days ago49% |
Aroon ODDS (%) | 2 days ago67% | 2 days ago55% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AMEFX | 26.63 | 0.09 | +0.34% |
American Funds Income Fund of Amer F2 | |||
FPHAX | 24.88 | N/A | N/A |
Fidelity Select Pharmaceuticals Port | |||
FMGGX | 49.71 | N/A | N/A |
Franklin Small-Mid Cap Growth R6 | |||
JIAFX | 9.38 | N/A | N/A |
JHancock Multi-Asset High Income A | |||
CNWGX | 21.15 | -0.03 | -0.14% |
Calamos Evolving World Growth A |
A.I.dvisor tells us that USHY and SM have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that USHY and SM's prices will move in lockstep.
Ticker / NAME | Correlation To USHY | 1D Price Change % | ||
---|---|---|---|---|
USHY | 100% | +0.19% | ||
SM - USHY | 26% Poorly correlated | -1.76% | ||
PTEN - USHY | 20% Poorly correlated | -0.17% |